These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

683 related items for PubMed ID: 16989901

  • 1. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
    PKC-DRS2 GroupBeetham Eye Institute, Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215, USA. LPAiello@Joslin.Harvard.edu, Aiello LP, Davis MD, Girach A, Kles KA, Milton RC, Sheetz MJ, Vignati L, Zhi XE.
    Ophthalmology; 2006 Dec; 113(12):2221-30. PubMed ID: 16989901
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2).
    Sheetz MJ, Aiello LP, Shahri N, Davis MD, Kles KA, Danis RP, Mbdv Study Group.
    Retina; 2011 Jun; 31(6):1053-9. PubMed ID: 21386766
    [Abstract] [Full Text] [Related]

  • 5. Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.
    Davis MD, Sheetz MJ, Aiello LP, Milton RC, Danis RP, Zhi X, Girach A, Jimenez MC, Vignati L, PKC-DRS2 Study Group.
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):1-4. PubMed ID: 18708615
    [Abstract] [Full Text] [Related]

  • 6. Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial.
    PKC-DMES Study Group.
    Arch Ophthalmol; 2007 Mar; 125(3):318-24. PubMed ID: 17353401
    [Abstract] [Full Text] [Related]

  • 7. Diabetic macular oedema and visual loss: relationship to location, severity and duration.
    Gardner TW, Larsen M, Girach A, Zhi X, Protein Kinase C Diabetic Retinopathy Study (PKC-DRS2) Study Group.
    Acta Ophthalmol; 2009 Nov; 87(7):709-13. PubMed ID: 19817721
    [Abstract] [Full Text] [Related]

  • 8. Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy.
    Girach A, Aiello LP, Milton RC, Davis MD, Danis RP, Zhi X, Sheetz MJ, Vignati L, PKC-DRS2 Study Group.
    Eye (Lond); 2009 Jan; 23(1):209-14. PubMed ID: 18989348
    [Abstract] [Full Text] [Related]

  • 9. The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized clinical trial.
    PKC-DRS Study Group.
    Diabetes; 2005 Jul; 54(7):2188-97. PubMed ID: 15983221
    [Abstract] [Full Text] [Related]

  • 10. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr EJ, MBBQ Study Group.
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M.
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [Abstract] [Full Text] [Related]

  • 12. Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.
    Sahu AK, Majji AB.
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6890; author reply 6890-1. PubMed ID: 21123772
    [No Abstract] [Full Text] [Related]

  • 13. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
    Lin JM, Chiu YT, Hung PT, Tsai YY.
    Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
    [Abstract] [Full Text] [Related]

  • 14. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
    Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G, Bastyr EJ, Wolka AM, Vinik AI.
    Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
    [Abstract] [Full Text] [Related]

  • 15. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J, Studnicka J, Rencová E, Korda V, Hejcmanová D.
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [Abstract] [Full Text] [Related]

  • 16. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.
    Kim SJ, Equi R, Bressler NM.
    Ophthalmology; 2007 May; 114(5):881-9. PubMed ID: 17275910
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients.
    Aiello LP, Clermont A, Arora V, Davis MD, Sheetz MJ, Bursell SE.
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):86-92. PubMed ID: 16384948
    [Abstract] [Full Text] [Related]

  • 18. Ruboxistaurin: LY 333531.
    Drugs R D; 2007 Jan; 8(3):193-9. PubMed ID: 17472415
    [Abstract] [Full Text] [Related]

  • 19. [A grid pattern type of photocoagulation in treatment of diabetic maculopathy--personal experience].
    Romaniuk W, Kozioł H, Markowska J, Fronczek M, Klimek J, Strojek K.
    Klin Oczna; 2000 Jan; 102(3):183-6. PubMed ID: 11126173
    [Abstract] [Full Text] [Related]

  • 20. Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
    Shimura M, Yasuda K, Nakazawa T, Kano T, Ohta S, Tamai M.
    Ophthalmology; 2003 Dec; 110(12):2386-94. PubMed ID: 14644723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.